5th to 11th November 2012

beepedblacksmithUrban and Civil

Nov 29, 2013 (3 years and 9 months ago)

103 views

CEDHYS Business tour in ISRAËL

5th to 11th
November

2012

1

CEDHYS Business tour in Israël

Table of contents


Attendees

presentation



2

CEDHYS Business tour in Israël

BIOGARAN: Antoine JUMELLE


June 2010



Present

(2 years 3 months):
CIO of
BIOGARAN
Biogaran

is the second Pharmaceutical Generic's
Laboratory in France.


2001



June 2010

(9 years)
IT Division Manager

at
Servier

Privately Held; 10,001+ employees;
Pharmaceuticals industry

+ IT Quality Manager

+ IT Security Survey Manager

+ International IT Coordination (140 countries)

+ Project Leader SAP Finance for the main French affiliate



1996



2001

(5 years):
IT Department Manager

at
Servier


Technical & Support Department (2500 users)

-

Workstations Policy (
Harware
-
Software
-
Contract
Negociations
)

-

Supports (2500 users
-

25 000 calls / year)

-

Networks LAN/CAN

-

Movings


CEDHYS Business tour in Israël

3

French Laboratory,
Biogaran

markets more than 530 generic medications. His philosophy is to produce all
genericable

molecules, the blockbuster drug and more confidential. Whatever the origin of the laboratory
"
princeps
" (parent drug).

Results: a range that can treat more than 80 diseases.

Biogaran

goes further: the laboratory since its inception has become an ethical approach that recognizes the
limits of medicine. For
Biogaran

drugs are active substances to be used properly. His commitment is backed by
concrete actions towards a better use of medicines and better monitoring of treatment (compliance) by the
patient.
Biogaran

invests a portion of its profits in this process through the establishment of free services (or
cost):


Tools secure daily use of the drug (creation of packages which facilitate the transmission of treatment doctor,
pharmacist and patient, clear and legible notices)

Services to reduce certain risk behaviors among young women (creating a mobile cover to reduce opportunities
to forget his regular contraception)

Services to reduce certain risk behaviors among children (creation of the case
Médikid

to promote safer
treatments transmission between nearby)

Services to facilitate the practice of medication at home.

BOUCHARA
-
RECORDATI: Jean VINCENEUX


Since 2005: BOUCHARA RECORDATI (400 employees)


IT MANAGER


FRANCE
Laboratoires

BOUCHARA RECORDATI is a subsidiary of RECORDATI group,
located in Milan.

I have the responsibility of IT department for all sites in France, including the

administrative offices (Levallois
-
Perret), the factories (St
-
Victor and Nanterre) and

ORPHAN Europe Company (Paris


La
Défense
). I report directly to RECORDATI CIO


From 2004 to 2005: BOUCHARA RECORDATI (400 employees)


IT Project manager

I was responsible for implementation of different IT projects especially for SAP

software, sales and distribution modules

CEDHYS Business tour in Israël

4

Recordati
, established in 1926, is a European pharmaceutical group, listed on the

Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271),

with a total staff of over 3,200, dedicated to the research, development,

manufacturing and marketing of pharmaceuticals. It has headquarters in Milan, Italy,

operations in the main European countries, in Central and Eastern Europe and in

Turkey. A field force of around 1,700 medical representatives promotes a wide range

of innovative pharmaceuticals, both proprietary and under license, in a number of

therapeutic areas including a specialized business dedicated to treatments for rare

diseases.
Recordati

is a partner of choice for new product licenses from companies

which do not have a European presence.
Recordati

is committed to the research

and development of new drug entities within the cardiovascular and
urogenital

therapeutic areas and of treatments for rare diseases. Consolidated revenue for 2011

was


762.0 million, operating income was


163.5 million and net income was


116.4 million.

CEVA: François TRICOT


Chief Information Officer at CEVA Santé
Animale


Over 15 years of multicultural experience in the IT industry, in various management positions (Skill Centre
Manager,
Cief

Information Officer)



April 2008
-

Present (4 years 5 months):

-

Transform group IT to match the challenges of today and tomorrow

-

Foster
organisation

and structure


February 2006
-

March 2008 (2 years 2 months): Manager at Aspire


Aspire is the largest
Capgemini

outsourcing services project with more than 5000 staff delivering IT solutions to
HMRC, the UK tax agency

-

Implemented productivity improvements in the Test discipline (a 400 people skill centre),

-

Industrialised

delivery practices for productivity improvements
-

Accelerated Delivery Centre (a 200 people

business unit),

-

Defined architecture principles of a massively scalable architecture for the HMRC internet portal (several

million users, peak usage for Self
-
Assessment) (a 100 people project)


CEDHYS Business tour in Israël

5

Ceva

Santé
Animale

is one of the Top 10 veterinary health company.
Ceva's

expertise
centres

are on the two

fields of pharmacology and biology, and has dedicated teams that aim to meet the specific demands of the

companion animal, poultry, ruminant and swine sectors.
Ceva's

operation are all around the globe in 42 countries,

with 21 factories and 13 R&D centers. About 3000 people work at
Ceva

and the fast growing turnover is above

500 M

.

DANONE
Research
: Laurent ANTIBI


Information Systems Director
Danone

Group



February 2007


Present (5 years 8 months)



Information Systems Director in charge of R&D function and Research Centers



June 2003


January 2007 (3 years 8 months)
Danone

Group Head Quarters



Project Director
in charge of CRM and Web Solutions



September 2000


May 2003 (2 years 9 months)
Danone

headquarters



CRM IS Manager
:
Multichanel

Marketing
Campain

Management
-

consumer database

CEDHYS Business tour in Israël

6

Danone

Group, a
french

company , world leader in food industry

101 000 people / 19,3 b


turn over

4 divisions : Dairy, Waters, Baby Food, Medical Nutrition

Nutrition for Health is at the heart of
Danone

‘s Strategy

Flamel Technologies: Raphaël COMMARET


Information
Technology

Manager,
since

2003


Flamel Technologies R&D, Pharmaceutical
Industry

(~250
employees
)


Also

in charge of the
compliance

of IT
systems

with

FDA
regulation

and
Sarbanes
-
Oxley
act
.



2000
-
2003:
Accenture

Consulting &
technology

services
company
:
IT consultant



7

CEDHYS Business tour in Israël

Flamel

Technologies SA (NASDAQ: FLML) is a leading drug delivery company focused on the goal

of developing safer, more efficacious formulations of drugs to tackle unmet medical needs.


Our product development pipeline includes biological and chemical drugs formulated with our

proprietary platforms :


-

Medusa platform (
injectable

drugs) allows formulation and/or extended release of biologics

(including proteins, antibodies and peptides) and also small molecules.

Several Medusa
-
based products are at various clinical stages of development; Medusa’s lead

internal product candidate IFN
-
a XL is currently the subject of a Phase 2 trial in HCV patients.

DeliVax
®, Medusa’s vaccine application, permits the efficient formulation of vaccines.


-

Micropump

platform (oral drugs) allows formulation and controlled release of chemical drugs

that are best absorbed in the small intestine.


-

LiquiTime
® allows extended release liquid formulations of drugs for patients who have difficulty

swallowing tablets or capsules, particularly children and the elderly.


-

Trigger Lock™ allows tamper
-
resistant controlled release formulations of narcotics and other

drugs susceptible to abuse.

GALDERMA: Thierry BARSALOU

Dr. Thierry
Barsalou

is
Chief Information Officer
for
Galderma
, a fully integrated pharmaceutical

company exclusively focused on dermatology. As CIO, Thierry has global responsibility over

Information Technology throughout the company. Thierry brings 30 years of experience in

the technology and healthcare industries alternating between successful start
-
ups and varied

positions of increasing responsibility at large companies such as IBM, Novartis and
Ipsen
. He

has lived and worked in France, the US, Switzerland, Canada and Belgium. Thierry holds an

MD degree from University of Paris, France, and a PhD in Medical Information Sciences from

Stanford University.

CEDHYS Business tour in Israël

8

Galderma

is a global pharmaceutical company founded in 1981 and exclusively focused on

dermatology. The company has 31 wholly
-
owned affiliates and 4,000 employees.
Galderma’s

extensive product portfolio treats a range of dermatological conditions including: acne,
rosacea
,

onychomycosis
, psoriasis & steroid
-
responsive
dermatoses
,
pigmentary

disorders, skin cancer

and medical solutions for skin senescence. In 2011,
Galderma

acquired Q
-
Med, a Swedish

medical device company specialized in aesthetics, strengthening
Galderma’s

presence in the

aesthetic and corrective market. With approximately 19% of revenues invested each year to

discover and develop new products and access innovative technologies, the company is one of

the world’s leading investors in dermatology R&D.

LFB: Jean
-
Louis QUEVA


2004



Present

(8 years):
CIO
at

LFB


2001



2003

(3 years):
Hypermarket CIO

at CARREFOUR



1996



2001

(5 years):
International Project Manager

at AIR LIQUIDE


CEDHYS Business tour in Israël

9

LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the
treatment of serious and often rare diseases in major therapeutic areas: immunology,
haemostasis
, and
intensive care.



LFB group is the leading manufacturer of plasma
-
derived medicinal products in France and the 6th largest
player worldwide. It is also among the leading European companies in the development of monoclonal
antibodies and new
-
generation proteins based on biotechnologies.



With its strong research activities, LFB group is developing a growth strategy to expand its business
activities by offering new therapeutic treatments and expanding into new international markets.


NUTRICIA: France GENNEQUIN


Since Feb.2009 :
IS Director
of NUTRICIA


2001


2008 : DANONE GROUP :

o 2004


2008 :
IT Operations Project Manager + Application Administration Manager


In charge of the projects for all IT Operations of
Danone



33 customer companies, 8000 users, worldwide
implementation. Coordination of 120 IT People.



o 2003 :
IS Deployment Manager
:
Dannon

US &
Danone

Canada


In charge of the deployment of SAP in
Danone

Canada and The
Dannon

Company, Inc.



o 2001


2002 :
Development Manager
of
Danone

Group


In charge of realizing all R/3 developments for the Core SAP System of
Danone

and for the 1s deployment wave


2000 :
Deployment Project Manager
at SODEXHO acting as Director of the SAP Competency Center


1999 :
SAP Consultant
at CMG


1997 :
Study & Development Engineer
at AXA

CEDHYS Business tour in Israël

10

Nutricia

Nutrition Clinique SAS is the French business unit of « Medical Nutrition »

division of
Danone

Group. Our products are intended for the nutritional management

of diseases and medical conditions (malnourished adults, metabolic disorder,

complete nutrition for patients who cannot meet their nutritional needs orally, etc.).

They are used under the direction of Healthcare professionals.


Nutricia

Nutrition Clinique sells & distributes nutrition products via several distribution

canals (Pharmacies, Hospitals, Wholesalers, Homecare professionals) in France and

export (DOM
-
POM, Maghreb). It is a business unit of 180 employees (half sales

force, half HQ) for a 2011 CA of 107 M


STAGO: Jean
-
Marc OBENICHE


Since

2010 : STAGO,
DIRECTOR IT


in charge of innovations and management control.



1993


2010 : STAGO,
C.I.O.



1989


1993 : FROMAGERIES BEL


Cheese

maker
company

(
Laughing

cow
,
Babybel
..),
Development

Manager


1985


1989 : Laboratoires JANSSEN
-

(JOHNSON & JOHNSON
affiliate
)

Office automation and Lan
Manager

CEDHYS Business tour in Israël

11

Stago

is a pharmaceutical laboratory, founded in 1945, which now operates in the

In vitro Diagnosis (IVD) industry, wholly dedicated to the exploration of
haemostasis

and thrombosis. (Reagents and devices)

STALLERGENES: Thierry GREHAIGNE


from 1996 till today

STALLERGENES S.A.,
Pharmaceutical lab, Worldwide leader in immunotherapy
(desensitization to allergies). 250M


of revenues, 40% out of France. 1.000 employees.


Vice
-
President Information Technologies



Staff

: 35 people, annual OPEX

: 3,5 M

, annual CAPEX

: 4,5 M



Building of a new Corporate Information System (based on M3, ERP from LAWSON/INFOR
Company) with deployment throughout Headquarters and affiliates


Implementation of E.DI. flows with third
-
party companies, for payment of the delivered products
to patients (more than 3.000 deliveries per day)


Due diligence coordination before acquisition of a competitor


Implementation of a new Company organization for management of transformation and product
development projects.


From1994 to 1996


CORNING FRANCE,
Scientific & ophthalmic glass manufacturer, affiliate of
CORNING Inc., worldwide leader in technical glass and optical fiber. 450 MF of turnover, 70% out of France. 600
employees.




Supply chain & IT Director

CEDHYS Business tour in Israël

12

Stallergenes

is a European biopharmaceutical company dedicated to the treatment of allergy
-
related

respiratory diseases, such as severe
rhinoconjunctivitis

and rhinitis, as well as allergic asthma, using

allergen immunotherapy. The leader in sublingual immunotherapy treatment,
Stallergenes

devotes

almost 20% of its gross sales to Research & Development and is actively involved in the development

of a new therapeutic class: sublingual immunotherapy tablets.

In 2011, the company had sales of


235 million, and more than 500,000 patients were treated with

Stallergenes

products.

URGO: Patrice CAULFUTY


January 2003



Present

(8 years 9 months):
Chief Information Officer (CIO) of
Laboratoires

Urgo

Privately Held; 1300 employees; Pharmaceuticals industry (manufacture solutions to treat common ailments and
high
-
tech healing products)

Define the IT strategy and policy (ERP SAP, Development,
Lan
, Wan,
Labtop
, web …)

Management of the IT Department (20 people)

International IT Coordination (15 affiliates)

IT Quality Manager (FDA compliance)

Responsible for SAP Roll out projects in Europe and Asia (5 countries)

Roll out CRM
SalesForce

and CLM (
Skura
) software in Asia




1998



2002

(4 years):
IT Department Manager

at
Laboratoires

Fournier Privately Held; 4000+ employees;
Pharmaceuticals industry

SAP skill Department manager (10 people)

Support and maintenance in SAP (upgrade, customizing …)

IT Security Manager

Roll out SAP in 5 countries




13

CEDHYS Business tour in Israël

Laboratoires

Urgo’s

Healthcare Division focuses its
expertise on reference brands:
Urgo
, the top foot, hand
and wound care brand is extending its leadership to
mouth wounds with
Urgo

Mouth Ulcers and Cold Sores.
Humex
, No. 1 in the upper respiratory tract infection
market, is strongly positioned in the cold and allergy

segments with, in particular, its hay fever treatment
containing
Beclomethasone
. A historic player in these
markets,
Urgo

Healthcare expanded its expertise to
create a third major section dedicated to

vitamin supplements in 2004. The launch of
ImmunoStim

in 2006 and the acquisition of
Alvityl

in 2008 have
enabled it to further strengthen its position and become a
key player in the child and family health segment.

Urgo

Healthcare makes the health URGO & HUMEX

of these “
consum
-
actors” its central focus, offering

them safe, effective and innovative products.

Voted most innovative OTC company in pharmacies in
2009,
Urgo

Healthcare is continuing to grow thanks to its
drive for innovation and expertise, enabling it to offer its
customers advanced, high
-
tech solutions.


*

URGO MEDICAL,

a reference for health professionals

Urgo

Medical, a wound
-
healing expert, is committed to working

with health professionals day after day to advance knowledge in

the field of wounds and develop innovative treatments designed

to improve patients’ quality of life and help them heal more quickly.

Today,
Urgo

Medical offers high
-
tech solutions for the treatment

of serious and incapacitating conditions: burns, pressure sores, leg

ulcers,
epidermolysis

bullosa
, diabetic foot ulcers.
Urgo

Medical’s

teams strive on a daily basis to meet their commitment to relieve pain,

simplify treatments and make life easier for patients.

In 2000,
Urgo

Medical
revolutionised

the wound healing

market by inventing Technology
Lipido
-
Colloid (TLC)


leading to the

development of
Urgotul
®


establishing itself as the gold standard

in the management of acute wounds.

Using “Pressure System” technology developed as a result of

Urgo

Research,
Urgo

Medical created the first compression system with
two active bandages in 2008: UrgoK2. In 2011, a new technological and
scientific advance with
UrgoStart
*, a healing accelerator treatment.


VETOQUINOL: Pierre
-
Yves COLIN


12/06
-

now : VETOQUINOL (Lure)


Group Director, Information System

Member of Group Steering
Committee


Definition and implementation of IT strategy of
Vetoquinol

Group. Management of IT team (40 people). Annual
budget 6,5 M


over 24 affiliates.


Creation and
structuration

of Group IT Department,
JDEdwards

ERP
Programm

roll out in Spain, Poland, India,
USA. Implementation of LIMS, Group CRM, Business Intelligence.


Direct management of IT of several affiliates

: USA, Canada and India.


01/03
-

12/06

: GROSFILLEX (
Oyonnax
)


Organization and Information System Director


Definition and implementation of the IT Strategy of
Grosfillex
. Management of IT teams (20people). Direct
management of USA and Russia’s IT.


Business process redesign projects

: French logistic reorganization (charter, transport
planification

and
purchases), audit of material flows (semi
-
finished) within “Window” division then implementation of
tracability
,
monitoring procedures and dashboards. Implementation of new logistic standards regarding transportation
costs.


North America

: Audit and improvement (sales forecasts, production
planification
, supply).


Implementation of MOVEX ERP.

Russia : Active participation to the creation of the
russian

affiliate (back
-
office, industrial
andlogistics
) Implementation of 1C local ERP.

CEDHYS Business tour in Israël

14

The

10th

largest

veterinary

pharmaceutical

company

in

the

world

and

the

3rd

largest

dedicated

to animal health,
Vétoquinol

is first and foremost an independent, family
-
owned business. Deeply committed to its values, it has always
enjoyed a close relationship with its vet clients.


Vétoquinol’s

growth and development strategy focuses on innovation and finding the right balance between two major
markets: companion animals and livestock, bred for human food.


Historically

based

in

France,

Vétoquinol

currently

develops,

produces

and

distributes

a

wide

range


of

more

than

700

medical

and

non
-
medical

products

in

Europe,

Americas

and

Asia
-
Pacific.

With


a

presence

in

23

countries

through

its

subsidiaries,

its

strong

network

of

140

distributor

partners


provides

visibility

for

its

products

in

more

than

100

countries.

VIRBAC: Patrick LALOUETTE


Since

02/2002 :
CIO

of VIRBAC SA (French Group)
with

3500 p (35
subsidiaries

/ 8 plants
worldwide
)
PHARMACY


Animal
Health


2001
-
2002: CIO of LVMH
Fashion

Group Division 4Mds Eu (13 brands & 220p in IT .) LUXURY AND LEATHER
GOODS (Vuitton, Kenzo,
Celine
, Givenchy, Lacroix, etc. ..) (Distribution
-

Retail

with

980 stores)


1998
-
2001 CIO division of VIVENDI UNIVERSAL PUBLISHING 1100 p 1 billion (+100p. in IT) SERVICES


CEDHYS Business tour in Israël

15

Founded in 1968 in
Carros
, near Nice,
Virbac

is dedicated exclusively to animal health. With a turnover of
623 million
euros

in 2011, the company now occupies 8th veterinarian pharmaceutical group worldwide.


Its wide range of vaccines and medicines used to prevent and treat major diseases of pets and livestock.